Discover the full management transaction log of Kane Biotech Inc., a listed equity based in Canada. Shares are listed on CA CA, under the supervision of SEDI. Operating in the Health Care sector, Kane Biotech Inc. has published 12 reports. Market capitalisation: €4.5m. The latest transaction was filed on 2 June 2026 (50 - Grant of options). Among the most active insiders: Renaud, Philip. All data is openly available.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.